To further investigate how PCK2-mediated gluconeogenesis inhibits apoptotic cell death of NSCLC cells, we tested the expressions of caspase 9, caspase 3, PARP and their cleaved forms in A549 and H1975 after PCK2 silencing. The gene discussed is CASP3; the disease is non-small cell lung carcinoma.